Venous leg ulcer
Conditions
Brief summary
Incidence of complete debridement, clinically (visually) assessed after each application during the Daily Visits Period (up to 8 applications),, Incidence of complete wound closure, clinically assessed from the initiation of study treatment until the end of the Weekly Visits Period.
Detailed description
Incidence of complete healthy viable granulation tissue, at the end of the Daily Visits Period, as assessed clinically, Time to the first declaration of complete debridement, clinically assessed, from the initiation of study treatment until the end of the Weekly Visits Period, Time to complete wound closure, clinically assessed, from the initiation of study treatment, until the end of the Weekly Visits Period
Interventions
Sponsors
Mediwound Ltd.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of complete debridement, clinically (visually) assessed after each application during the Daily Visits Period (up to 8 applications),, Incidence of complete wound closure, clinically assessed from the initiation of study treatment until the end of the Weekly Visits Period. | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of complete healthy viable granulation tissue, at the end of the Daily Visits Period, as assessed clinically, Time to the first declaration of complete debridement, clinically assessed, from the initiation of study treatment until the end of the Weekly Visits Period, Time to complete wound closure, clinically assessed, from the initiation of study treatment, until the end of the Weekly Visits Period | — |
Countries
Austria, Germany, Italy, Poland
Outcome results
None listed